UB Paderborn / Katalog / Suche / in CDI

On the basis of sex: male vs. female rat adenosine A1/A2A receptor affinity

BMC research notes, 2023-08, Vol.16 (1), p.1-165, Article 165

2023

Volltextzugriff (PDF)

In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0231521-e0231521

2022

Volltextzugriff (PDF)

C2-substituted quinazolinone derivatives exhibit A1 and/or A2A adenosine receptor affinities in the low micromolar range

Bioorganic & medicinal chemistry letters, 2020-08, Vol.30 (16), p.127274-127274, Article 127274

2020

Volltextzugriff (PDF)

1,3,7-Triethyl-substituted xanthines—possess nanomolar affinity for the adenosine A1 receptor

Bioorganic & medicinal chemistry, 2015-10, Vol.23 (20), p.6641-6649

2015

Volltextzugriff (PDF)

Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A 1 and A 2A adenosine receptors

Chemical biology & drug design, 2018-01, Vol.91 (1), p.234-244

2018

Volltextzugriff (PDF)

Evaluation of chemical constituents of Rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia) as adenosine A1/A2A receptor ligands

Medicinal chemistry research, 2023-12, Vol.32 (12), p.2535-2548

2023

Volltextzugriff (PDF)

Imidazo[1,2-α]pyridines possess adenosine A1 receptor affinity for the potential treatment of cognition in neurological disorders

Bioorganic & medicinal chemistry letters, 2017-09, Vol.27 (17), p.3963-3967

2017

Volltextzugriff (PDF)

Methoxy substituted 2-benzylidene-1-indanone derivatives as A and/or A AR antagonists for the potential treatment of neurological conditions

MedChemComm, 2019-02, Vol.1 (2), p.3-39

2019

Volltextzugriff (PDF)

Benzopyrone represents a privilege scaffold to identify novel adenosine A1/A2A receptor antagonists

Bioorganic chemistry, 2018-04, Vol.77, p.136-143

2018

Volltextzugriff (PDF)

Benzyloxynitrostyrene analogues – A novel class of selective and highly potent inhibitors of monoamine oxidase B

European journal of medicinal chemistry, 2017-01, Vol.125, p.1193-1199

2017

Volltextzugriff (PDF)

Methoxy substituted 2-benzylidene-1-indanone derivatives as A 1 and/or A 2A AR antagonists for the potential treatment of neurological conditions

MedChemComm, 2019-02, Vol.10 (2), p.300-309

2019

Volltextzugriff (PDF)

2-Aminopyrimidines as dual adenosine A1/A2A antagonists

European journal of medicinal chemistry, 2015-11, Vol.104, p.177-188

2015

Volltextzugriff (PDF)

Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report

Lipids in health and disease, 2011-08, Vol.10 (1), p.152-152

2011

Volltextzugriff (PDF)

Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A1 and A2A receptor antagonists

Bioorganic & medicinal chemistry letters, 2016-12, Vol.26 (24), p.5951-5955

2016

Volltextzugriff (PDF)

8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activity

Toxicology in vitro, 2018-12, Vol.53, p.114-120

2018

Volltextzugriff (PDF)

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions

MedChemComm, 2019-02, Vol.10 (2), p.300-309

2019

Volltextzugriff (PDF)

The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues

Bioorganic chemistry, 2015-04, Vol.59, p.117-123

2015

Volltextzugriff (PDF)

The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines

Bioorganic chemistry, 2013-08, Vol.49, p.49-58

2013

Volltextzugriff (PDF)

Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6632-6635

2012

Volltextzugriff (PDF)

Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B

Bioorganic & medicinal chemistry letters, 2012-12, Vol.22 (24), p.7367-7370

2012

Volltextzugriff (PDF)

Evaluation of 2‐benzylidene‐1‐tetralone derivatives as antagonists of A1 and A2A adenosine receptors

Chemical biology & drug design, 2018-01, Vol.91 (1), p.234-244

2018

Volltextzugriff (PDF)

On the basis of sex: male vs. female rat adenosine A 1 /A 2A receptor affinity

BMC research notes, 2023-08, Vol.16 (1), p.165

2023

Volltextzugriff (PDF)

Benzopyrone represents a privilege scaffold to identify novel adenosine A 1 /A 2A receptor antagonists

Bioorganic chemistry, 2018-04, Vol.77, p.136

2018

Volltextzugriff (PDF)

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8md00540k

MedChemComm, 2019-01, Vol.10 (2), p.300-309

2019

Volltextzugriff (PDF)

The adenosine A2A antagonistic properties of selected C8-substituted xanthines

Bioorganic chemistry, 2013-08, Vol.49, p.49-58

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

On the basis of sex: male vs. female rat adenosine A1/A2A receptor affinity

In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis

C2-substituted quinazolinone derivatives exhibit A1 and/or A2A adenosine receptor affinities in the low micromolar range

1,3,7-Triethyl-substituted xanthines—possess nanomolar affinity for the adenosine A1 receptor

Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A 1 and A 2A adenosine receptors

Evaluation of chemical constituents of Rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia) as adenosine A1/A2A receptor ligands

Imidazo[1,2-α]pyridines possess adenosine A1 receptor affinity for the potential treatment of cognition in neurological disorders

Methoxy substituted 2-benzylidene-1-indanone derivatives as A and/or A AR antagonists for the potential treatment of neurological conditions

Benzopyrone represents a privilege scaffold to identify novel adenosine A1/A2A receptor antagonists

Benzyloxynitrostyrene analogues – A novel class of selective and highly potent inhibitors of monoamine oxidase B

Methoxy substituted 2-benzylidene-1-indanone derivatives as A 1 and/or A 2A AR antagonists for the potential treatment of neurological conditions

2-Aminopyrimidines as dual adenosine A1/A2A antagonists

Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report

Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A1 and A2A receptor antagonists

8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activity

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions

The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues

The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines

Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B

Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B

Evaluation of 2‐benzylidene‐1‐tetralone derivatives as antagonists of A1 and A2A adenosine receptors

On the basis of sex: male vs. female rat adenosine A 1 /A 2A receptor affinity

Benzopyrone represents a privilege scaffold to identify novel adenosine A 1 /A 2A receptor antagonists

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8md00540k

The adenosine A2A antagonistic properties of selected C8-substituted xanthines

Suchergebnisse filtern